Related Experiment Video
Updated: May 22, 2026
08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Commonly performed procedures in clinical research: a benchmark for payment
Dinora Dominguez1, Mandy Jawara, Nicole Martino
1Office of Communications, Patient Recruitment, and Public Liaison, NIH Clinical Center, USA.
Contemporary Clinical Trials
|May 15, 2012
Summary
This study establishes payment benchmarks for clinical research participants using four years of data. The findings offer guidance for determining appropriate compensation for research participation, addressing a gap in current literature.
Area of Science:
- Clinical Research
- Health Economics
- Research Ethics
Background:
- Clinical trial enrollment is often slow, necessitating effective participant recruitment strategies.
- Existing literature on compensating research participants primarily addresses ethical concerns, lacking practical guidelines for payment amounts.
- There is a need for data-driven benchmarks to assist investigators and IRBs in determining fair payment for clinical research participation.
Purpose of the Study:
- To establish payment benchmarks for commonly performed clinical research procedures.
- To provide data to guide investigators and institutional review boards (IRBs) in setting participant compensation.
- To address the lack of established formulas or guidelines for calculating participant payments.
Main Methods:
- Analysis of four years of data (August 2004-August 2008) on inconvenience units assigned to clinical research procedures.
- Utilized data from 36,273 payment incidents at the National Institutes of Health (NIH) Clinical Center.
- Examined the value assigned to specific procedures to identify payment benchmarks.
Main Results:
- Identified payment benchmarks for various clinical research procedures based on assigned inconvenience units.
- Data analysis revealed a convergence in payment practices for most procedures, despite outliers.
- This study presents one of the first published reports on specific payment amounts for clinical research procedures.
Conclusions:
- The established payment benchmarks can inform investigators and IRBs when determining participant compensation.
- The findings support the development of payment standards for clinical research procedures.
- This data complements existing proposals for calculating participant payments based on time and procedures.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.